Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

An Expanding Role for Nuclear Factor κB in Muscle Stem Cells: Implications for the Treatment of Duchenne Muscular Dystrophy

Proto, Jonathan D (2013) An Expanding Role for Nuclear Factor κB in Muscle Stem Cells: Implications for the Treatment of Duchenne Muscular Dystrophy. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

Primary Text

Download (4MB) | Preview


Duchenne muscular dystrophy (DMD) is a fatal disease characterized by progressive skeletal muscle degeneration. Inhibition of the transcription factor nuclear factor-κ B (NF-κB), and more specifically the p65 subunit, significantly improves the phenotype of mdx mice, a murine DMD model. However, the ubiquity of NF-κB stands as an obstacle to clinical translation. In this dissertation, we explore the roles of NF-κB/p65 in the regenerative capacity of muscle-derived stem cells (MDSCs) with the goal of identifying alternative approaches to DMD treatment. We found that both cell proliferation and myogenic potential were increased in MDSCs lacking one allele of p65 (p65+/-). In wild type MDSCs, in vitro pharmacologic inhibition of the upstream activating kinase, IKKβ, increased myotube formation in a dose-dependent manner. When transplanted into mdx hind limb muscle, p65+/- MDSCs resulted in significantly larger engraftments. Furthermore, engraftments in cardiotoxin (CTX) injured muscle were associated with reduced local host necrosis and inflammation. Not only were p65+/- MDSCs found to be more resistant to oxidative stress, but we found that p65 depletion improved the anti-inflammatory capacity of MDSCs in vitro and in vivo via upregulation of hepatocyte growth factor (HGF). Moreover, accelerated regeneration in p65 haploinsufficient mdx mice (mdx;p65+/-) coincided with HGF upregulation. Intraperitoneal injection of a musculotropic adeno-associated virus carrying shRNA targeting HGF reversed the phenotypic improvements of mdx;p65+/- mice, increasing both muscle inflammation and necrosis. These data implicate NF-κB/p65 in muscle stem cell proliferation, differentiation, survival, and growth factor gene expression, further underlining the danger of broadly targeting such an important pathway. Finally, this research has also identified HGF as a downstream effector of NF-κB/p65 inhibition in mdx mice. Thus, delivery of HGF or activation of its receptor, MET, may represent a new approach to reduce chronic inflammation and preserve muscle fiber integrity in DMD.


Social Networking:
Share |


Item Type: University of Pittsburgh ETD
Status: Unpublished
CreatorsEmailPitt UsernameORCID
Proto, Jonathan
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Thesis AdvisorHuard, Johnnyjhuard@pitt.eduJHUARD
Committee ChairMars, Wendy Mwmars@pitt.eduWMARS
Committee MemberNiedernhofer, Laura
Committee MemberRobbins, Paul
Committee MemberStolz, Donna Bdstolz@pitt.eduDSTOLZ
Committee MemberPiganelli, Jon Djdp51@pitt.eduJDP51
Date: 4 December 2013
Date Type: Publication
Defense Date: 16 September 2013
Approval Date: 4 December 2013
Submission Date: 4 December 2013
Access Restriction: 1 year -- Restrict access to University of Pittsburgh for a period of 1 year.
Number of Pages: 132
Institution: University of Pittsburgh
Schools and Programs: School of Medicine > Cellular and Molecular Pathology
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: stem cells, muscular dystrophy, inflammation, HGF, NF-kappaB, MDSC, skeletal muscle, myogenesis
Date Deposited: 04 Dec 2013 16:39
Last Modified: 15 Nov 2016 14:16


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item